MU-1656

N/A

Report date: 2026/01/13 17:56:52
NME

Base Information

Drug NameMU-1656
Drug Alias NameMU-1656
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDOT1 like histone lysine methyltransferase inhibitors
TargetsDOT1 like histone lysine methyltransferase
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMasaryk University
China Registration ClassN/A

Develop Information

Active CompaniesMasaryk University
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A